Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07336251 · ClinicalTrials.gov registry record · NA
Transcranial Magnetic Stimulation in Veterans With PTSD
A NA study of PTSD - Post Traumatic Stress Disorder, sponsored by White River Junction Veterans Affairs Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT07336251: Recruiting NA study of PTSD - Post Traumatic Stress Disorder, sponsored by White River Junction Veterans Affairs Medical Center.
NCT07336251 is a NA study of PTSD - Post Traumatic Stress Disorder that is actively recruiting participants, run by White River Junction Veterans Affairs Medical Center. The registered enrollment target is 20 participants, below the 278-participant average among 14 other PTSD - Post Traumatic Stress Disorder trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07336251, a NA study of PTSD - Post Traumatic Stress Disorder, is actively recruiting participants, sponsored by White River Junction Veterans Affairs Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
With this research investigators hope to begin to understand how rTMS can improve posttraumatic stress disorder (PTSD) symptoms. TMS improves PTSD through two interrelated mechanisms: change in brain limbic system function and change in systemic inflammatory activation. Participants who decide to join this study, will receive ten rTMS treatments. All participants will undergo a 40-minute rTMS procedure with a member of the study team 10 times over 2-4 weeks. Participants will undergo fMRI scans of the head in order to help researchers better understand potential effects of rTMS on brain activity. In addition, participants will be asked to give two breath and blood samples to look for signs of general inflammation.
Primary Outcome
The CAPS is a clinician-administered scale of PTSD symptoms, which queries the frequency and intensity of symptoms of PTSD
Conditions Studied
Interventions
- DEVICE Transcranial Magnetic Stimulation
Study Locations (1)
Vermont
- White River Junction VA Hospital - White River Junction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-01-15 |
| Est. Completion | 2027-01 |
| Phase | NA |
What NCT07336251 shows while recruiting
NCT07336251 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 278-participant average among 14 other PTSD - Post Traumatic Stress Disorder trials with a reported enrollment target (93% lower).
The record links to 1 condition, with PTSD - Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 1 intervention - of which Transcranial Magnetic Stimulation is the first listed.
NCT07336251 reports a single indexed study location in Vermont.
Frequently Asked Questions
What is clinical trial NCT07336251 about?
NCT07336251 is a clinical study titled "Transcranial Magnetic Stimulation in Veterans With PTSD". With this research investigators hope to begin to understand how rTMS can improve posttraumatic stress disorder (PTSD) symptoms. TMS improves PTSD through two interrelated mechanisms: change in brain limbic system function and change in systemic inflammatory activation. Participants who decide to jo...
What is the current status of trial NCT07336251?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-01-15. Estimated completion is 2027-01.
What conditions does trial NCT07336251 study?
This clinical trial studies the following conditions: PTSD - Post Traumatic Stress Disorder.
What interventions are being tested in trial NCT07336251?
The interventions under investigation include: Transcranial Magnetic Stimulation (DEVICE).
Who is sponsoring clinical trial NCT07336251?
This trial is sponsored by White River Junction Veterans Affairs Medical Center, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07336251 being conducted?
This trial has 1 study location across Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD - Post Traumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07336251's enrollment target sits among peer trials
20 13th of 14 higher than 1 of 14 other PTSD - Post Traumatic Stress Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PTSD - Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment for PTSD and Tinnitus
RECRUITING · NA
-
Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD
RECRUITING · NA
-
Diet and Microbiome Interactions: Application in Posttraumatic Stress Disorder in Adults Consuming Vegetable Drinks
RECRUITING · NA
-
Empowering Perinatal Adolescents Through Writing
RECRUITING · NA
-
Restorative Early Sleep Treatment After the Emergency Department
RECRUITING · NA
-
Evaluating Evidenced Based Options for PTSD Treatment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI